Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1967 Jun;30(2):417–424. doi: 10.1111/j.1476-5381.1967.tb02148.x

The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.

S H Ferreira, J R Vane
PMCID: PMC1557274  PMID: 6036419

Full text

PDF
417

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUMPUS F. M., SMEBY R. R., PAGE I. H., KHAIRALLAH P. A. DISTRIBUTION AND METABOLIC FATE OF ANGIOTENSIN II AND VARIOUS DERIVATIVES. Can Med Assoc J. 1964 Jan 25;90:190–193. [PMC free article] [PubMed] [Google Scholar]
  2. FASCIOLO J. C. FORMATION AND DESTRUCTION OF PLASMA KININS. Acta Physiol Lat Am. 1964;14:170–179. [PubMed] [Google Scholar]
  3. Ferreira S. H., Vane J. R. The detection and estimation of bradykinin in the circulating blood. Br J Pharmacol Chemother. 1967 Mar;29(3):367–377. doi: 10.1111/j.1476-5381.1967.tb01968.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HAMBERG U., ROCHA E., SILVA M. Studies on the enzymatic inactivation of bradykinin. Acta Physiol Scand. 1954;30(2-3):215–225. doi: 10.1111/j.1748-1716.1954.tb01089.x. [DOI] [PubMed] [Google Scholar]
  5. HORTON E. W. Human urinary kinin excretion. Br J Pharmacol Chemother. 1959 Mar;14(1):125–132. doi: 10.1111/j.1476-5381.1959.tb00938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MCCARTHY D. A., POTTER D. E., NICOLAIDES E. D. AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN. J Pharmacol Exp Ther. 1965 Apr;148:117–122. [PubMed] [Google Scholar]
  7. Nobili M. B. Sulla inattivazione della eledoisina e della physalaemina da parte del sangue totale e di omogenati tessutali di alcuni vertebrati. Arch Int Pharmacodyn Ther. 1965 Nov;158(1):187–201. [PubMed] [Google Scholar]
  8. OATES J. A., MELMON K., SJOERDSMA A., GILLESPIE L., MASON D. T. RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME. Lancet. 1964 Mar 7;1(7332):514–517. doi: 10.1016/s0140-6736(64)92907-1. [DOI] [PubMed] [Google Scholar]
  9. SAAMELI K., ESKES T. K. Bradykinin and cardiovascular system: estimation of half-life. Am J Physiol. 1962 Aug;203:261–265. doi: 10.1152/ajplegacy.1962.203.2.261. [DOI] [PubMed] [Google Scholar]
  10. STURMER E., BERDE B. A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin. J Pharmacol Exp Ther. 1963 Jun;140:349–355. [PubMed] [Google Scholar]
  11. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. VANE J. R. THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964 Oct;23:360–373. doi: 10.1111/j.1476-5381.1964.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zeitlin I. J., Smith A. N. 5-hydroxyindoles and kinins in the carcinoid and dumping syndromes. Lancet. 1966 Nov 5;2(7471):986–991. doi: 10.1016/s0140-6736(66)92924-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES